Data are presented of 368/503 post-COVID-19 outpatients followed within the AntiCROWN Cohort who have a one-year control and a baseline assessment of anti-S1/S2 antibodies, detected with the The LIAISON® SARS-CoV-2 S1/S2 IgG solution by DiaSorin. Loss of response occurred in 4 subjects having a baseline level below 50 AU/mL.
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG / A.F. Capetti, F. Borgonovo, D. Mileto, G. Gagliardi, C. Mariani, A. Lupo, G. Dedivitiis, P. Meraviglia, M. Pellicciotta, L. Armiento, M.V. Cossu, G. Rizzardini. - In: JOURNAL OF INFECTION. - ISSN 0163-4453. - 83:2(2021 Aug), pp. 241-244. [10.1016/j.jinf.2021.05.023]
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
A.F. CapettiPrimo
;F. BorgonovoSecondo
;D. Mileto;G. Gagliardi;
2021
Abstract
Data are presented of 368/503 post-COVID-19 outpatients followed within the AntiCROWN Cohort who have a one-year control and a baseline assessment of anti-S1/S2 antibodies, detected with the The LIAISON® SARS-CoV-2 S1/S2 IgG solution by DiaSorin. Loss of response occurred in 4 subjects having a baseline level below 50 AU/mL.
| File | Dimensione | Formato | |
|---|---|---|---|
|
23.JournalOfInfection-6-9.pdf
accesso riservato
Descrizione: Letter
Tipologia:
Publisher's version/PDF
Dimensione
937.29 kB
Formato
Adobe PDF
|
937.29 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
